ABUS Operating Cash Flow Growth
Arbutus Biopharma Corp · Operating Cash Flow Growth
ABUS Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported61.79%period ending
ABUS Quarterly Cash from Operations YoY % (-132.96% → 61.79%)
Year-over-year change
High-resolution chart · PNG
ABUS operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 61.7881% | |
| 39.4369% | |
| 54.6292% | |
| 71.9473% | |
| -8.5838% | |
| 30.5986% | |
| 40.3481% | |
| 4.8109% | |
| 25.8449% | |
| 29.3249% | |
| -1.7775% | |
| -16.5418% | |
| 3.617% | |
| -232.407% | |
| 13.3429% | |
| -16.5627% | |
| -44.8569% | |
| 215.3123% | |
| -30.5935% | |
| -31.7233% | |
| -59.1751% | |
| -15.7122% | |
| -12.4485% | |
| 48.1295% | |
| 50.0085% | |
| 6.7973% | |
| 21.8097% | |
| -77.7492% | |
| 0.0965% | |
| 16.963% | |
| -65.1035% | |
| 15.7908% | |
| -247.0264% | |
| -13.8694% | |
| 30.2253% | |
| -6.5797% | |
| 69.781% | |
| -51.8708% | |
| 10.8022% | |
| -482.1923% | |
| -0.7978% | |
| 35.2912% | |
| -142.7257% | |
| 62.3958% | |
| -108.1273% | |
| -294.899% | |
| -368.1512% | |
| -84.5828% | |
| -188.1367% | |
| 420.7031% | |
| -93.7302% | |
| -176.788% | |
| -58.3706% | |
| 33.0171% | |
| 30,045.5343% | |
| -2,092.7279% | |
| 57.9805% | |
| -35.4113% | |
| 96.4044% | |
| 97.3811% | |
| -5,358.9829% | |
| 40.0956% | |
| -114.3922% | |
| -141.6782% | |
| 104.8428% | |
| -492.2978% | |
| -5.1586% | |
| 71.9752% | |
| 41.5285% | |
| -43.1061% | |
| -262.3336% | |
| -132.96% |